Notch 1 mutation in lymphoma and leukemia
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial looks for a specific genetic change (Notch 1 mutation) in people with chronic lymphocytic leukemia (CLL) or non-Hodgkin's lymphoma (NHL). It aims to better understand the disease and may lead to more targeted treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with chronic lymphocytic leukemia (CLL) or non-Hodgkin's lymphoma (NHL).
- You need to agree to sign a consent form to participate.
- You cannot be currently receiving chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a specific gene variant in people with newly diagnosed chronic lymphocytic leukemia (CLL). It may help researchers understand CLL better and how genetics could affect the disease.
This study collects blood and tumor tissue samples from people newly diagnosed with aggressive non-Hodgkin lymphoma who will receive standard chemotherapy. The goal is to improve future tests for detecting minimal residual disease (tiny amounts of cancer left after treatment).
This study is examining levels of a protein called LEF1 in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Researchers want to see if LEF1 can help predict survival and confirm diagnosis.
This trial looks for a DNA marker in people with HLH caused by lymphoma. It may help doctors better confirm the cause of HLH and guide treatment decisions.
This trial tests an experimental drug, QLS2313, for people with certain types of blood cancer (B-cell non-Hodgkin lymphoma or chronic lymphocytic leukemia/small lymphocytic lymphoma) that have not gotten better with other treatments. The goal is to see if the drug is safe and works.
This study is a registry that collects information about people with certain types of leukemia. It may help researchers understand the disease course and how patients are treated, including people who are newly diagnosed, currently treated, referred for transplant, or have relapsed.
Hear when a new Chronic Lymphocytic Leukemia (CLL)- Non-Hodgins's Lymphoma (NHL) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.